Table 2.
Comparison of postoperative complications in patients with hepatitis C and control subjects
| Complication | 1466 patients with hepatitis C | 21,502 control subjects | OR (95% CI) | p Value |
|---|---|---|---|---|
| Number (%) | Number (%) | |||
| Infection | ||||
| Within 3 months | 25 (2%) | 215 (1%) | 1.7 (1.1–2.6) | 0.015 |
| Within 6 months | 45 (3%) | 384 (2%) | 1.7 (1.3–2.4) | 0.001 |
| Within 1 year | 88 (6%) | 630 (3%) | 2.1 (1.7–2.7) | < 0.001 |
| Revision TSA | ||||
| Within 1 year | 50 (3%) | 492 (2%) | 1.5 (1.1–2.0) | 0.008 |
| Within 2 years | 70 (5%) | 669 (3%) | 1.6 (1.2–2.0) | 0.001 |
| Dislocation (1 year) | 56 (4%) | 510 (2%) | 1.6 (1.2–2.2) | 0.001 |
| Stiffness (1 year) | 126 (9%) | 1665 (8%) | 1.1 (0.9–1.4) | 0.260 |
| Loosening (1 year) | 21 (1%) | 202 (1%) | 1.5 (1.0–2.4) | 0.085 |
| Fracture (1 year) | 32 (2%) | 263 (1%) | 1.8 (1.2–2.6) | 0.002 |
| Systemic (3 months) | 87 (6%) | 988 (5%) | 1.3 (1.0–1.6) | 0.022 |
| Transfusion (3 months) | 192 (13%) | 1799 (8%) | 1.7 (1.4–1.9) | < 0.001 |
TSA = total shoulder arthroplasty; OR = odds ratio.